Adcock Ingram Integrated Report 2018

ANNUAL FINANCIAL STATEMENTS 128 ADCOCK INGRAM  Integrated Report 2018 Annexure H – Interest in subsidiary companies, associate and joint ventures Shareholding Subsidiaries 2018 % 2017 % Adcock Ingram Critical Care Proprietary Limited 100 100 Adcock Ingram Healthcare Proprietary Limited 100 100 Adcock Ingram Intellectual Property Proprietary Limited 100 100 Adcock Ingram International Proprietary Limited 100 100 Adcock Ingram Limited 100 100 Tender Loving Care – Hygienic, Cosmetic and Baby Products Proprietary Limited* 100 100 Joint ventures Adcock Ingram Limited (India) 49.9 49.9 Thembalami Pharmaceuticals Proprietary Limited* 50 50 Indirect holdings Adcock Ingram East Africa Limited (Kenya) 100 100 Adcock Ingram Intellectual Property No 1 Proprietary Limited* 100 100 Adcock Ingram Pharmaceuticals Proprietary Limited* 100 100 Addclin Research Proprietary Limited* 100 100 Ayrton Drug Manufacturing Limited (Ghana) 25.1 25.1 Datlabs (Private) Limited (Zimbabwe) 100 100 Dilwed Investments Proprietary Limited 100 100 Genop Holdings Proprietary Limited 100 – Genop Healthcare Proprietary Limited 100 – Menarini SA Proprietary Limited** 49 49 Metamorphosa Proprietary Limited* 50 50 National Renal Care Proprietary Limited 50 50 Novartis Ophthalmics Proprietary Limited** 49 49 Pharmalabs (Jersey) Limited 100 100 Premier Pharmaceutical Company Proprietary Limited* 100 100 Relicare Tech Services Private Limited (India) 100 100 Virtual Logistics Proprietary Limited 100 100 Trusts and structured entities AdBEE (RF) Limited*** Adcock Ingram Holdings Limited Employee Share Trust (2008) Ad-Izinyosi (RF) Proprietary Limited*** Mpho ea Bophelo Trust 39 Owner-driver companies (2017: 28 companies) * Dormant entities. ** Regarded as subsidiaries and consolidated. *** Not consolidated